AbbVie Inc.
ABBV
$210.60
$1.100.53%
NYSE
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 15.59% | -11.65% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 15.59% | -11.65% | |||
Cost of Revenue | 8.60% | -8.96% | |||
Gross Profit | 18.58% | -12.75% | |||
SG&A Expenses | -0.96% | 11.64% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 3.80% | -2.96% | |||
Operating Income | 42.54% | -26.66% | |||
Income Before Tax | -6.44% | 173.20% | |||
Income Tax Expenses | 64.78% | 116.56% | |||
Earnings from Continuing Operations | -27.00% | 5,704.35% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | 0.00% | -400.00% | |||
Net Income | -27.06% | 5,945.45% | |||
EBIT | 42.54% | -26.66% | |||
EBITDA | 28.50% | -20.15% | |||
EPS Basic | -27.27% | 4,087.29% | |||
Normalized Basic EPS | 51.13% | -31.12% | |||
EPS Diluted | -27.78% | 3,950.27% | |||
Normalized Diluted EPS | 51.23% | -31.28% | |||
Average Basic Shares Outstanding | 0.00% | -0.06% | |||
Average Diluted Shares Outstanding | -0.06% | 0.17% | |||
Dividend Per Share | 0.00% | 0.00% | |||
Payout Ratio | 0.36% | 1.02% |